Morphic Therapeutic
Biotech · Acquired
Oral small-molecule integrin inhibitors for inflammatory bowel disease and fibrosis
morphictx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 17 granted · 23 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1319 | ONCA BIO, INC. | — | — |
| 1320 | OASIS PHARMACEUTICALS, LLC | — | — |
| 1321 | DRIVE THERAPEUTICS, L.L.C. | — | — |
| 1322 | Morphic Therapeutic | — | — |
| 1323 | LEFLORE TECHNOLOGIES LLC | — | — |
| 1324 | NRG Therapeutics | — | — |
| 1325 | Senseion Therapeutics, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- INHIBITORS OF AV ß6 INTEGRINgranted
- Inhibitors Of (ALPHA-V)(BETA-6) Integringranted
- Inhibiting (ALPHA-V)(BETA-6) Integringranted
- Integrin ALPHA-7 BETA-1 Antibodies And Uses Thereofapplication
- Inhibitors Of (ALPHA-V)(BETA-6) Integringranted
- Inhibitors Of (ALPHA-V)(BETA-6) Integrinapplication
- USE OF INTEGRIN a5b1 INHIBITORS IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILUREapplication
- Antagonists Of Human Integrin (ALPHA4)(BETA7)granted
- Inhibitors Of (ALPHA-V)(BETA-6) Integringranted
- Inhibiting Human Integrin (ALPHA-4) (BETA-7)application
- Inhibitors Of (ALPHA-V)(BETA-6) Integringranted
- Inhibitors Of (ALPHA-V)(BETA-6) Integringranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.